Vidarabine Phosphate

Vidarabine Phosphate

SCHEMBL144996

Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 5/20 1.00
▸ P2RY2 P41231 3/20 1.00
▸ SRC P12931 2/20 1.00
▸ SMN1; SMN2 Q16637 2/20 1.00
▸ TRPM2 O94759 2/20 1.00
▸ TAS1R3 Q7RTX0 2/20 1.00
▸ TAS1R1 Q7RTX1 2/20 1.00
▸ DNPH1 O43598 1/20 1.00
▸ PRKAB2 O43741 1/20 1.00
▸ LDHA P00338 1/20 1.00
▸ ADRB2 P07550 1/20 1.00
▸ FBP1 P09467 1/20 1.00
▸ ADORA1 P30542 1/20 1.00
▸ PRKAG1 P54619 1/20 1.00
▸ PRKAA2 P54646 1/20 1.00
▸ PDE4D Q08499 1/20 1.00
▸ KCNH2 Q12809 1/20 1.00
▸ PRKAA1 Q13131 1/20 1.00
▸ PDE3A Q14432 1/20 1.00
▸ P2RY11 Q96G91 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenosine Phosphate SCHEMBL1338615 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL14478782 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL144997 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL13374692 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL15646670 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL2683103 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL18785114 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL8572634 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL5588 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL13170051 1.00 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1536 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122075514-A Use of glycogen phosphatase B agonists for the treatment of neurodegenerative diseases — 2026-05-26 — — CN claimed
WO-2026043843-A1 TETRAHYDROPYRIMIDINE (THP) IONIZABLE LIPIDS FOR EFFICIENT MRNA DELIVERY THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) 2026-02-26 — — WO claimed
CN-222922066-U Shading storage device for vidarabine monophosphate 开封明仁药业有限公司 2025-05-30 — — CN claimed
US-20250025426-A1 SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES Karlsruher Institut für Technologie (DE) 2025-01-23 — — US claimed
US-12145951-B2 Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) 2024-11-19 — — US claimed
CN-118806783-A Application of vidarabine phosphate in preparation of medicine for treating liver ischemia reperfusion injury 浙江大学 2024-10-22 — — CN claimed
WO-2024215771-A1 SUBSTITUTED PHENYL ETHYNYL PYRIMIDINES AS POTENT INHIBITORS OF ALPHAVIRUSES SOUTHERN RESEARCH INSTITUTE (US) 2024-10-17 — — WO claimed
CN-115919823-B Application of benserazide hydrochloride in preparing medicament for treating diseases caused by respiratory syncytial virus 浙江艾特为生物科技有限公司 2024-04-05 — — CN claimed
CN-113173957-B Synthesis method and application of vidarabine monophosphate 海南锦瑞制药有限公司 2023-10-27 — — CN claimed
EP-4262812-A1 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS Southern Research Institute (US) 2023-10-25 — — EP claimed
EP-0731703-B1 LIPOSOMAL FORMULATIONS CONTAINING VIDARABINE OR ITS DERIVATIVES INST NAC DE ENGENHARIA E TECNO (PT) 2003-09-10 — — EP claimed
WO-2003055464-A1 MICRONIZED PHARMACEUTICAL OR NUTRACEUTICAL POWDER WITH IMMEDIATE RELEASE BESINS INTERNATIONAL BELGIQUE (BE) 2003-07-10 — — WO claimed
US-20030124191-A1 Use of an immediate-release powder in pharmaceutical and nutraceutical compositions GALENIX INNOVATIONS (FR) 2003-07-03 — — US claimed
US-6576636-B2 Treating a noncentral nervous system by administering a covalent conjugate of a C8-26, unbranched, naturally occurring fatty acid and a drug, provided the drug is not an adenosine receptor agonist/antagonist; anticarcinogenics PROTARGA, INC. 2003-06-10 — — US claimed
WO-2003043612-A1 MICRONIZED FILM-FORMING POWDER COMPRISING AN ACTIVE SUBSTANCE BESINS INTERNATIONAL BELGIQUE (BE) 2003-05-30 — — WO claimed
US-20030096012-A1 Film-forming powder, compositions containing it, methods for their preparation and their uses GALENIX INNOVATIONS (FR) 2003-05-22 — — US claimed
WO-2003030934-A2 CPG FORMULATIONS AND RELATED METHODS MERIAL LIMITED (US) 2003-04-17 — — WO claimed
WO-2001097749-A2 THE USE OF SYNTHETIC, NON-HORMONAL 21-AMINOSTEROIDS AND THEREOF KOTZE, GAVIN, SALOMON (ZA) 2001-12-27 — — WO claimed
EP-0731703-A1 LIPOSOMAL FORMULATIONS CONTAINING VIDARABINE OR ITS DERIVATIVES INSTITUTO NACIONAL DE ENGENHARIA E TECNOLOGIA INDUSTRIAL/INSTITUTO DE BIOTECNOLOGIA, QUIMICA FINA E TECNOLOGIAS ALIMENTARES (PT) 1996-09-18 — — EP claimed
WO-1995015762-A1 LIPOSOMAL FORMULATIONS CONTAINING VIDARABINE OR ITS DERIVATIVES INSTITUTO NACIONAL DE ENGENHARIA E TECNOLOGIA INDUSTRIAL/INSTITUTO DE BIOTECNOLOGIA, QUÍMICA FINA E TECNOLOGIAS ALIMENTARES (PT) 1995-06-15 — — WO claimed
Send feedback